Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
UiPath Inc (NYSE: PATH) closed the day trading at $12.44 down -1.19% from the previous closing price of $12.59. In other words, the price has decreased by -$1.19 from its previous closing price. On the day, 9.87 million shares were traded. PATH stock price reached its highest trading level at $12.59 during the session, while it also had its lowest trading level at $12.36.
Ratios:
For a better understanding of PATH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.77. For the most recent quarter (mrq), Quick Ratio is recorded 2.82 and its Current Ratio is at 2.82. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Macquarie Downgraded its Outperform to Neutral on June 03, 2024, whereas the target price for the stock was revised from $29 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’25 when Dines Daniel sold 45,000 shares for $13.18 per share. The transaction valued at 592,920 led to the insider holds 6,453,376 shares of the business.
Dines Daniel sold 45,000 shares of PATH for $590,508 on May 13 ’25. The CEO and Chairman now owns 6,498,376 shares after completing the transaction at $13.12 per share. On May 12 ’25, another insider, Dines Daniel, who serves as the CEO and Chairman of the company, sold 45,000 shares for $12.83 each. As a result, the insider received 577,494 and left with 6,543,376 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PATH now has a Market Capitalization of 6653745152 and an Enterprise Value of 5308870656. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.65 while its Price-to-Book (P/B) ratio in mrq is 3.73. Its current Enterprise Value per Revenue stands at 3.713 whereas that against EBITDA is -43.158.
Stock Price History:
The Beta on a monthly basis for PATH is 1.02, which has changed by -0.36498213 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, PATH has reached a high of $20.50, while it has fallen to a 52-week low of $9.38. The 50-Day Moving Average of the stock is 10.11%, while the 200-Day Moving Average is calculated to be -1.17%.
Shares Statistics:
Over the past 3-months, PATH traded about 12.81M shares per day on average, while over the past 10 days, PATH traded about 7114190 shares per day. A total of 471.06M shares are outstanding, with a floating share count of 403.11M. Insiders hold about 24.25% of the company’s shares, while institutions hold 56.13% stake in the company. Shares short for PATH as of 1745971200 were 43542991 with a Short Ratio of 3.40, compared to 1743379200 on 30163274. Therefore, it implies a Short% of Shares Outstanding of 43542991 and a Short% of Float of 10.12.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
